Following the findings of its ability to act as a satiety factor, the functional role of SPX was further examined in obesity/ fat metabolism-related diseases, such as metabolic syndrome and diabetes mellitus (37–39). The gene discussed is SPX; the disease is obesity due to melanocortin 4 receptor deficiency.